DaVita HealthCare Partners Inc. (NYSE: DVA), a leading global provider of kidney care services and a leading independent medical group in the United States, today announced plans to begin operations in Brazil. The company, which operates in 11 countries serving more than 1.5 million patients, aims to bring its global expertise and leading clinical outcomes to the country.
DaVita plans to help Brazilian physicians grow their practice by providing them access to a worldwide network of experts, best-in-class training programs and the most advanced clinical and administrative service standards.
"Our objective in Brazil, as it is in all the countries in which DaVita HealthCare Partners operates, is to deliver world-class care and improve quality of life for our patients," said Dennis Kogod, CEO of DaVita's international operations. "In addition to bringing DaVita's leading kidney care services to the country, we look forward to partnering with the Brazilian government and payors in establishing and expanding integrated care functions."
"We have a proven clinical system focused on improving health care services, which allows physicians to achieve great results and spend more time with their patients," said Dr. Mahesh Krishnan, international chief medical officer and group vice president of research and development at DaVita. "DaVita invests heavily in clinical research and clinical innovation to improve the model of patient care, and, ultimately, patient outcomes."
There are more than 110,000 Brazilians on dialysis, a number that many studies suggest is on the rise due to the increasing prevalence of chronic kidney disease in the country.
Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients